NASDAQ:SRPT   Sarepta Therapeutics, Inc.
$SRPT RSI looking oversold on the daily chart, held trend line support well today. Expecting a bounce in the near/medium term.
Targeting $160 at least by next earnings release late October.




Note: Informational analysis, not investment advice.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.